9:30—11:00 AM
Center for Global Development
2055 L St, NW
- Fifth Floor
Washington, DC 20036

A Bitter Pill: Assuring the Quality, Safety, and Affordability of Generic Medicines


- Katherine Eban, Investigative Journalist and Author of Bottle of Lies
Jen Kates, Senior Vice President and Director of Global Health and HIV Policy, Kaiser Family Foundation
Amanda Glassman, Executive Vice President and Senior Fellow, CGD
- Prashant Yadav, Visiting Fellow, CGD


Sean Bartlett, Director of Communications, CGD


Janeen Madan Keller, Assistant Director of Global Health Policy and Senior Policy Analyst, CGD


Quality affordable generic medicines play a vital role in health systems around the world. Healthy competition from quality generic medicines can help keep prices in check—a shared concern across high-income and low- and middle-income countries. But CGD’s Working Group on the Future of Global Health Procurement found that markets for generic medicines in many low- and middle-income countries are failing. According to the final report, weak and under-resourced regulatory and quality control systems in many countries can often lead healthcare workers and patients to opt for more expensive branded medicines as a proxy for quality.

Join us for a panel discussion on the challenges in generic medicines markets and what can be done to ensure that people around the world have access to quality affordable medicines and other lifesaving health products. The conversation will focus on the implications for global health policy and the role of international cooperation. Investigative journalist Katherine Eban will also share relevant findings from her new book, Bottle of Lies: The Inside Story of the Generic Drug Boom, which uncovers fraud and falsification in generic drug manufacturing.

Politics & Prose will have copies of "Bottle of Lies" available for purchase.

Subscribe today to receive CGD’s latest newsletters and topic updates.